Latest other current assets for ALRN: $810K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Aileron Therapeutics (ALRN) currently reports a other current assets of $810K as of June 2026. That compares with $880K in the prior-year period — down 8.4% year over year. Use the charts on this page to explore Aileron Therapeutics's other current assets history and peer comparisons.
Aileron Therapeutics's other current assets decreased from $880K to $810K — a 8.4% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Aileron Therapeutics reported $810K in other current assets as of June 2026. That compares with $880K in the prior-year period — down 8.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current other current assets of $810K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Aileron Therapeutics, and consider following ALRN for alerts when major investors trade the stock.
Aileron Therapeutics is classified in the Healthcare sector. On other current assets, it currently shows $810K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ALRN with unrelated industries.